HER2 testing recommendations in the UK: dual- or single-colour in-situhybrydisation?

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	379
Number of pages	1
Journal	Journal of Clinical Pathology
Volume	65
Issue number	4
DOIs	https://doi.org/10.1136/jclinpath-2011-200467
Publication status	Published - 2012

Keywords

@article{adbb94d9eb9a4659a81e3baa322ab0f7,

title = "HER2 testing recommendations in the UK: dual- or single-colour in-situhybrydisation?",

keywords = "BREAST-CANCER, CHROMOSOME-17 POLYSOMY, AMPLIFICATION",

author = "CB Moelans and \{van Diest\}, PJ",

year = "2012",

doi = "10.1136/jclinpath-2011-200467",

language = "English",

volume = "65",

pages = "379",

journal = "Journal of Clinical Pathology",

issn = "0021-9746",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - HER2 testing recommendations in the UK

T2 - dual- or single-colour in-situhybrydisation?

AU - Moelans, CB

AU - van Diest, PJ

PY - 2012

Y1 - 2012

KW - BREAST-CANCER

KW - CHROMOSOME-17 POLYSOMY

KW - AMPLIFICATION

U2 - 10.1136/jclinpath-2011-200467

DO - 10.1136/jclinpath-2011-200467

M3 - Comment/Letter to the editor

C2 - 22031588

SN - 0021-9746

VL - 65

SP - 379

JO - Journal of Clinical Pathology

JF - Journal of Clinical Pathology

IS - 4

ER -